DOCSLIB.ORG

PRAXAIR HEALTHCARE SERVICES INFORMATION SHEET HELIOX Heliox Is a Prepackaged Blend of Helium USP and Medical Oxygen USP

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PRAXAIR HEALTHCARE SERVICES INFORMATION SHEET HELIOX Heliox Is a Prepackaged Blend of Helium USP and Medical Oxygen USP PRAXAIR HEALTHCARE SERVICES INFORMATION SHEET HELIOX Heliox is a prepackaged blend of helium USP and medical oxygen USP. Conventionally, heliox has been supplied with helium at 70% or 80%, balanced with oxygen. Substituting helium for nitrogen in a gas mixture changes the physical properties of the inhaled gas decreasing density and increasing the propensity for laminar air flow in patients’ airways. The medical use of heliox as a breathable gas for respiratory disease was first introduced in 1934 by Barach1. Since then, heliox has been studied in a variety of upper and lower airway conditions. Reference 1. Barach, AL,. Use of helium as a new therapeutic gas. Proc Soc Exp Biol Med 1934; 32: 462-464 Information on heliox is available from ABSTRACTS FROM events sponsored by the American HELIOX PUBLICATIONS Association of Respiratory Care (AARC). Information on heliox is available • 2004 professor’s round by in scientific and medical literature, Michael Gentile, RRT “Helium such as the following articles: and Nitric Oxide – Getting the Helium/Oxygen-Driven Albuterol most of Alternative Gas Nebulization in the Treatment of Therapies”. Children With Moderate to Severe • Webcast on January 26, 2005 by Asthma Exacerbations: A Randomized, Dean Hess PhD RRT “Heliox Controlled Trial Therapy”. This webcast is available In K. Kim, MD; Erin Phrampus, on the AARC’s online continuing MD, MPH; Shekhar education system–until Dec 31, Venkataraman, MD; Raymond 2005. Pitetti, MD, MPH; Al Saville, 100% oxygen driven delivery • AARC’s 51st Annual Congress RRT; Timothy Corcoran, PhD; Ed in the treatment of asthmatic Saturday, December 3, 2005 Gracely, PhD; Nicole Funt, children with moderate to (1:00 pm to 4:50 pm) San Antonio MPAS, PA-C; and Ann severe exacerbations. Convention Center (Ballroom Thompson, MD Methods: We enrolled 30 children C), TX. A symposium on (Pediatrics 2005;116:1127-1133) aged 2 to 19 years who presented Heliox Therapy: Practice, Background: Helium and oxygen to an urban, pediatric emergency Evidence, Risk and mixtures (heliox) increase both department (ED) with moderate to Opportunities. Please check pulmonary aerosol delivery and severe asthma as defined by a AARC program for details. gas delivery relative to oxygen. pulmonary index (PI) score of We aimed to compare the greater pr equal to 8. PI scores can For further information, please effectiveness of a 70%:30% range from 0 to 15. In this ran- visit our web site: helium/oxygen (heliox) driven domized, controlled, single-blind http://www.praxair.com/heliox continuous aerosol delivery versus trial conducted in a convenience sample of children, all patients in the trial received early in an acute disease process. Any beneficial an initial nebulized albuterol (5 mg) treatment driven effect of heliox shall become evident in a relatively by 100% oxygen and a dose of oral prednisone or short period of time. The medical literature supports prednisolone. Subsequently, patients were randomly the use of heliox to relieve respiratory distress, assigned to receive continuously nebulized albuterol decrease the work of breathing, and improve gas (15 mg/hour) delivered by either heliox or oxygen exchange. No adverse effects of heliox have been using a nonrebreathing face mask. The primary reported. However, heliox must be administered outcome measure was degree of improvement as with vigilance and continuous monitoring to avoid assessed in blinded video-recorded PI scores over 240 technical complications. minutes (at 30-minute intervals for the first 3 hours) or until ED discharge (if <240 minutes). Helium-oxygen Reduces Work of Breathing in Mechanically Ventilated Patients with Chronic Results: The mean change in PI score from baseline Obstructive Pulmonary Disease to 240 minutes or ED discharge was 6.67 for the Marc Gainnier, Jean-Michael Arnal, Patrick heliox group compared with 3.33 for the oxygen group. Gerbeaux, Stephane Donati, Laurent Papazian, Eleven (73%) patients in the heliox group were Jean-Marie Sainty (Intensive Care Med 2003 discharged from the hospital in <12 hours, compared 29:1666-1670) with 5 (33%) patients in the conventional group. Objective: To evaluate whether helium-oxygen Conclusion: Continuously nebulized albuterol mixture reduces inspiratory work of breathing delivered by heliox was associated with a greater (WOB) in sedated, paralyzed, and mechanically degree of clinical improvement compared with that ventilated patients with acute exacerbation of delivered by oxygen among children with moderate chronic obstructive pulmonary disease (COPD). to severe asthma exacerbations. Design and setting: Open prospective, randomized, crossover study in the medical intensive care unit in Heliox Administration in the Pediatric Intensive Care Unit: a university hospital. An Evidence-Based Review Vineet K. Gupta, MD; Ira M. Cheifetz, MD, FCCM Patients and participants: 23 patients admitted (Pediatr Crit Care Med 2005; 6:204-211) for acute exacerbation of COPD and mechanically ventilated. Objective: To provide a comprehensive, evidence-based review of helium-oxygen gas Measurements: Total WOB (WOBt), elastic WOB mixtures (heliox) in the management of pediatric (WOBel), resistive WOB (WOBres), and WOB due respiratory diseases. to PEEPi (WOBPeepi) were measured. Static Data Source: A thorough, computerized bibliographic intrinsic positive and expiratory pressure (PEEPi) search of the preclinical and clinical literature static compliance (Crs), inspiratory resistance regarding the properties of helium and its application (Rins), inspiratory (tinsp), and expiratory time in pediatric respiratory disease states. constant (texp) were also measured. These Data Synthesis: After an overview of the potential variables were compared between air-oxygen and benefits and technical aspects of helium-oxygen gas helium-oxygen mixtures. mixtures, the role of heliox is addressed for asthma, Results: WOBt significantly decreased with aerosolized medication delivery, upper airway helium-oxygen (2.34±1.04 to 1.85±1.01 J/L, obstruction, postextubation stridor, croup, bronchiolitis, p<0.001). This reduction was significant for WOBel and high-frequency ventilation. The available data are (1.02±0.61 J/L to 0.87±0.47, p<0.01) WOBPeepi objectively classified based on the value of the (0.77±0.38 J/L to 0.54± 0.38, p<0.001), and therapy or intervention as determined by the study WOBres (0.55±0.19 J/L to 0.44±0.24, p<0.05). design from which the data are obtained. PEEPi, Rins, tinsp and texp significantly decreased. Conclusions: Heliox administration is most effective Crs was unchanged. during conditions involving density-dependent Conclusions: Helium-oxygen mixture decreases increases in airway resistance, especially when used WOB in mechanically ventilated COPD patients. Helium-oxygen mixture could with heliox leads to a more Demographic data, age, time be useful to reduce the burden significant improvement in elapsed from the start of the of ventilation. spirometry when compared with symptoms to the admission to albuterol nebulized with oxygen. PICU, length of stay in PICU The Utility of Albuterol Nebulized This is likely due to the low-den- (PICU-LOS), and duration of with Heliox During Acute sity gas improving albuterol heliox therapy were also Asthma Exacerbations deposition in the distal airways. collected for each patient. John P. Kress, Imre Noth, Brian Heliox Therapy in Infants with Reductions in clinical scores and K. Gehlbach, Nitin Barman, Acute Bronchiolitis PICU-LOS were considered Anne S. Pohlman, Annette primary outcomes. Federico Martinón-Torres, MD, Miller, Sherwin Morgan, and PhD; Antonio Rodríguez-Núñez, Main Results: At baseline, the Jesse B. Hall MD, PhD; and Jose María heliox and control groups had (Am J Respir Crit Care Med Vol. Martinón-Sánchez, MD, PhD similar age (5.5 ± 3.1 vs 5.9 ± 3 165 pp 1317-1321, 2002) Pediatrics 2002;109:68-73 months), previous length of course (47.3 ± 19.3 vs 45.4 ± Heliox improves lung deposition of Objective: To assess the thera- 18.6 hours), clinical score (6.7 ± inhaled particles when compared peutic effects of breathing a 1.1 vs 6.6 ± 1) heart rate (160 ± with air or oxygen inhalation. We low-density gas mixture (heliox: 24 vs 165 ± 20 beats per minute), studied the spirometric effects of 70% helium and 30% oxygen) in respiratory rate (64 ± 7 vs 61 ± 7 albuterol nebulized with heliox infants with bronchiolitis. during emergency room visits for respirations per minute), satO2 Design: Prospective, interventional, asthma exacerbations. Forty-five (91 ± 2.3 vs 91 ± 2.5%), and comparative study. patients were randomized to etCO2 (34 ± 7 vs 33 ± 6 mm Hg). receive albuterol nebulized with Setting: A pediatric intensive care Clinical score, heart rate, respira- oxygen (control) versus heliox unit (PICU) in a tertiary care, tory rate, and satO2 improved during (n = 22 control and 23 heliox teaching hospital. the study in both groups. After 1 subjects). At baseline, demographics, Patients: Thirty-eight infants, 1 hour, the improvement in clinical outpatient asthma medications, month to 2 years old, consecutively score was significantly higher in the vital signs, oxygen saturation, admitted to the PICU for treatment heliox group than in the control and forced expiratory volume in of moderate-to-severe acute group (3.6 ± 1.16 vs 5.5 ± 0.89), one second were not different respiratory syncytial virus and these differences continued between the two groups. Three bronchiolitis. to be significant at the end of the consecutive albuterol treatments observation period (2.39 ± 0.69 were given to each group. The Interventions: The first 19 patients and 4.07 ± 0.96, respectively), heliox group had a significantly were enrolled as the control with a total average decrease in higher heart rate after albuterol group, and received supportive the score of 4.2 points in the heliox nebulization compared with the care and nebulized epinephrine. group versus 2.5 points in the control group. Following albuterol In the next 19 patients, heliox control group. Heart and respira- Treatment 1, the median change therapy was added through a tory rates were also significantly in forced expiratory volume in nonrebreather reservoir face mask.
Load more

Recommended publications
  • Effect of an Indwelling Pleural Catheter Vs Talc Pleurodesis On
    This supplement contains the following items: 1. Original protocol, final protocol, summary of changes. 2. Original statistical analysis plan. There were no further changes to the original statistical analysis plan. Downloaded From: https://jamanetwork.com/ on 10/02/2021 The Australasian Malignant Pleural Effusion Trial (AMPLE) A Multicentre Randomized Study Comparing Indwelling Pleural Catheter vs Talc Pleurodesis in Patients with Malignant Pleural Effusions Ethics Registration number 2012-005 Protocol version number 1.0 Protocol date 10/01/2012 Authorised by: Name: Prof YC Gary Lee Role: Chief Investigator Signature: Date: 10/01/2012 Downloaded From: https://jamanetwork.com/ on 10/02/2021 General Information This document describes the Western Australian Randomised Malignant Effusion trial for the purpose of submission for review by the relevant human research and ethics committees. It provides information about procedures for entering patients into the trial and this protocol should not be used as a guide for the treatment of other patients; every care was taken in its drafting, but corrections or amendments may be necessary. Questions or problems relating to this study should be referred to the Chief Investigator or Trial Coordinator. Compliance The trial will be conducted in compliance with this protocol, the National Statement on Ethical Conduct in Human Research, data protection laws and other guidelines as appropriate. It will be registered with the Australia and New Zealand Clinical Trials Registry, once ethical approval is secured.
    [Show full text]
  • Vocal Cord Dysfunction JAMES DECKERT, MD, Saint Louis University School of Medicine, St
    Vocal Cord Dysfunction JAMES DECKERT, MD, Saint Louis University School of Medicine, St. Louis, Missouri LINDA DECKERT, MA, CCC-SLP, Special School District of St. Louis County, Town & Country, Missouri Vocal cord dysfunction involves inappropriate vocal cord motion that produces partial airway obstruction. Patients may present with respiratory distress that is often mistakenly diagnosed as asthma. Exercise, psychological conditions, airborne irritants, rhinosinusitis, gastroesophageal reflux disease, or use of certain medications may trigger vocal cord dysfunction. The differential diagnosis includes asthma, angioedema, vocal cord tumors, and vocal cord paralysis. Pulmo- nary function testing with a flow-volume loop and flexible laryngoscopy are valuable diagnostic tests for confirming vocal cord dysfunction. Treatment of acute episodes includes reassurance, breathing instruction, and use of a helium and oxygen mixture (heliox). Long-term manage- ment strategies include treatment for symptom triggers and speech therapy. (Am Fam Physician. 2010;81(2):156-159, 160. Copyright © 2010 American Academy of Family Physicians.) ▲ Patient information: ocal cord dysfunction is a syn- been previously diagnosed with asthma.8 A handout on vocal cord drome in which inappropriate Most patients with vocal cord dysfunction dysfunction, written by the authors of this article, is vocal cord motion produces par- have intermittent and relatively mild symp- provided on page 160. tial airway obstruction, leading toms, although some patients may have pro- toV subjective respiratory distress. When a per- longed and severe symptoms. son breathes normally, the vocal cords move Laryngospasm, a subtype of vocal cord away from the midline during inspiration and dysfunction, is a brief involuntary spasm of only slightly toward the midline during expi- the vocal cords that often produces aphonia ration.1 However, in patients with vocal cord and acute respiratory distress.
    [Show full text]
  • Full Text (PDF)
    REVIEW COPD Physiological and clinical relevance of exercise ventilatory efficiency in COPD J. Alberto Neder1, Danilo C. Berton1,2, Flavio F. Arbex3, Maria Clara Alencar4, Alcides Rocha3, Priscila A. Sperandio3, Paolo Palange5 and Denis E. O’Donnell1 Affiliations: 1Respiratory Investigation Unit and Laboratory of Clinical Exercise Physiology, Queen’s University and Kingston General Hospital, Kingston, ON, Canada. 2Division of Respiratory Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. 3Pulmonary Function and Clinical Exercise Physiology, Respiratory Division, Federal University of Sao Paulo, Sao Paulo, Brazil. 4Division of Cardiology, Federal University of Minas Gerais, Belo Horizonte, Brazil. 5Dept of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy. Correspondence: J. Alberto Neder, 102 Stuart Street, Kingston, Ontario, Canada K7L 2V6. E-mail: [email protected] @ERSpublications Ventilatory efficiency is a key measurement for the interpretation of cardiopulmonary exercise testing in COPD http://ow.ly/1nsY307pbz8 Cite this article as: Neder JA, Berton DC, Arbex FF, et al. Physiological and clinical relevance of exercise ventilatory efficiency in COPD. Eur Respir J 2017; 49: 1602036 [https://doi.org/10.1183/13993003.02036- 2016]. ABSTRACT Exercise ventilation (V′E) relative to carbon dioxide output (V′CO2) is particularly relevant to patients limited by the respiratory system, e.g. those with chronic obstructive pulmonary disease (COPD). ′ − ′ High V E V CO2 (poor ventilatory efficiency) has been found to be a key physiological abnormality in symptomatic patients with largely preserved forced expiratory volume in 1 s (FEV1). Establishing an ′ − ′ association between high V E V CO2 and exertional dyspnoea in mild COPD provides evidence that exercise intolerance is not a mere consequence of detraining.
    [Show full text]
  • The Use of Heliox in Treating Decompression Illness
    The Diving Medical Advisory Committee DMAC, Eighth Floor, 52 Grosvenor Gardens, London SW1W 0AU, UK www.dmac-diving.org Tel: +44 (0) 20 7824 5520 [email protected] The Use of Heliox in Treating Decompression Illness DMAC 23 Rev. 1 – June 2014 Supersedes DMAC 23, which is now withdrawn There are many ways of treating decompression illness (DCI) at increased pressure. In the past 20 years, much has been published on the use of oxygen and helium/oxygen mixtures at different depths. There is, however, a paucity of carefully designed scientific studies. Most information is available from mathematical models, animal experiments and case reports. During a therapeutic compression, the use of a different inert gas from that breathed during the dive may facilitate bubble resolution. Gas diffusivity and solubility in blood and tissue is expected to play a complex role in bubble growth and shrinkage. Mathematical models, supported by some animal studies, suggest that breathing a heliox gas mixture during recompression could be beneficial for nitrogen elimination after air dives. In humans, diving to 50 msw, with air or nitrox, almost all cases of DCI can be adequately treated at 2.8 bar (18 msw), where 100% oxygen is both safe and effective. Serious neurological and vestibular DCI with only partial improvements during initial compression at 18 msw on oxygen may benefit from further recompression to 30 msw with heliox 50:50 (Comex therapeutic table 30 – CX30). There have been cases successfully treated on 50:50 heliox (CX30), on the US Navy recompression tables with 80:20 and 60:40 heliox (USN treatment table 6A) instead of air and in heliox saturation.
    [Show full text]
  • Effect of Heliox Breathing on Flow Limitation in Chronic Heart Failure Patients
    Eur Respir J 2009; 33: 1367–1373 DOI: 10.1183/09031936.00117508 CopyrightßERS Journals Ltd 2009 Effect of heliox breathing on flow limitation in chronic heart failure patients M. Pecchiari*, T. Anagnostakos#, E. D’Angelo*, C. Roussos#, S. Nanas# and A. Koutsoukou# ABSTRACT: Patients with chronic heart failure (CHF) exhibit orthopnoea and tidal expiratory flow AFFILIATIONS limitation in the supine position. It is not known whether the flow-limiting segment occurs in the *Istituto di Fisiologia Umana I, Universita` degli Studi di Milano, peripheral or central part of the tracheobronchial tree. The location of the flow-limiting segment Milan, Italy, and can be inferred from the effects of heliox (80% helium/20% oxygen) administration. If maximal #Dept of Critical Care and Pulmonary expiratory flow increases with this low-density mixture, the choke point should be located in the Services, Evangelismos General central airways, where the wave-speed mechanism dominates. If the choke point were located in Hospital, Medical School, University of Athens, Athens, Greece. the peripheral airways, where maximal flow is limited by a viscous mechanism, heliox should have no effect on flow limitation and dynamic hyperinflation. CORRESPONDENCE Tidal expiratory flow limitation, dynamic hyperinflation and breathing pattern were assessed in M. Pecchiari 14 stable CHF patients during air and heliox breathing at rest in the sitting and supine position. Istituto di Fisiologia Umana I via L. Mangiagalli 32 No patient was flow-limited in the sitting position. In the supine posture, eight patients exhibited 20133 Milan tidal expiratory flow limitation on air. Heliox had no effect on flow limitation and dynamic Italy hyperinflation and only minor effects on the breathing pattern.
    [Show full text]
  • Respiratory Therapy Pocket Reference
    Pulmonary Physiology Volume Control Pressure Control Pressure Support Respiratory Therapy “AC” Assist Control; AC-VC, ~CMV (controlled mandatory Measure of static lung compliance. If in AC-VC, perform a.k.a. a.k.a. AC-PC; Assist Control Pressure Control; ~CMV-PC a.k.a PS (~BiPAP). Spontaneous: Pressure-present inspiratory pause (when there is no flow, there is no effect ventilation = all modes with RR and fixed Ti) PPlateau of Resistance; Pplat@Palv); or set Pause Time ~0.5s; RR, Pinsp, PEEP, FiO2, Flow Trigger, rise time, I:E (set Pocket Reference RR, Vt, PEEP, FiO2, Flow Trigger, Flow pattern, I:E (either Settings Pinsp, PEEP, FiO2, Flow Trigger, Rise time Target: < 30, Optimal: ~ 25 Settings directly or by inspiratory time Ti) Settings directly or via peak flow, Ti settings) Decreasing Ramp (potentially more physiologic) PIP: Total inspiratory work by vent; Reflects resistance & - Decreasing Ramp (potentially more physiologic) Card design by Respiratory care providers from: Square wave/constant vs Decreasing Ramp (potentially Flow Determined by: 1) PS level, 2) R, Rise Time (­ rise time ® PPeak inspiratory compliance; Normal ~20 cmH20 (@8cc/kg and adult ETT); - Peak Flow determined by 1) Pinsp level, 2) R, 3)Ti (shorter Flow more physiologic) ¯ peak flow and 3.) pt effort Resp failure 30-40 (low VT use); Concern if >40. Flow = more flow), 4) pressure rise time (¯ Rise Time ® ­ Peak v 0.9 Flow), 5) pt effort (­ effort ® ­ peak flow) Pplat-PEEP: tidal stress (lung injury & mortality risk). Target Determined by set RR, Vt, & Flow Pattern (i.e. for any set I:E Determined by patient effort & flow termination (“Esens” – PDriving peak flow, Square (¯ Ti) & Ramp (­ Ti); Normal Ti: 1-1.5s; see below “Breath Termination”) < 15 cmH2O.
    [Show full text]
  • Training Objectives for a Diving Medical Physician
    The Diving Medical Advisory Committee Training Objectives for a Diving Medicine Physician This guidance includes all the training objectives agreed by the Diving Medical Advisory Committee, the European Diving Technology Committee and the European Committee for Hyperbaric Medicine in 2011. Rev 1 - 2013 INTRODUCTION The purpose of this document is to define more closely the training objectives in diving physiology and medicine that need to be met by doctors already fully accredited or board-certified in a clinical speciality to national standards. It is based on topic headings that were originally prepared for a working group of European Diving Technology Committee (EDTC) and the European Committee of Hyperbaric Medicine (ECHM) as a guide for diving medicine some 20 years ago by J.Desola (Spain), T.Nome (Norway) & D.H.Elliott (U.K.). The training now required for medical examiners of working divers and for specialist diving medicine physicians was based on a EDTC/ECHM standard 1999 and subsequently has been enhanced by the Diving Medical Advisory Committee (DMAC), revised and agreed in principle by DMAC, EDTC and ECHM in 2010 and then ratified by EDTC and ECHM in 2011. The requirements now relate to an assessment of competence, the need for some training in occupational medicine, the need for maintenance of those skills by individual ‘refresher training’. Formal recognition of all this includes the need to involve a national authority for medical education. These objectives have been applied internationally to doctors who provide medical support to working divers. (Most recreational instructors and dive guides are, by their employment, working divers and so the guidance includes the relevant aspects of recreational diving.
    [Show full text]
  • A Review of the Use of Heliox in the Critically Ill
    Special review A Review of the use of Heliox in the Critically Ill T. WIGMORE, E. STACHOWSKI Intensive Care Unit, Westmead Hospital, Westmead, NEW SOUTH WALES ABSTRACT Heliox, a mix of oxygen and helium, has a number of potential medical applications resulting from its relatively lower density. This paper reviews the physics underlying its utility and considers the evidence for its use. While there are studies that support its role, particularly in patients with exacerbations of asthma and chronic obstructive pulmonary disease (COPD), the data are inconclusive. (Critical Care and Resuscitation 2006; 8: 64-72) Key words: Heliox, helium, airway obstruction, asthma, chronic obstructive pulmonary disease Helium was discovered in 1868 by the French astro- a given pressure difference. Clinically this can be utilis- nomer Pierre-Jules-Cesar Janssen during a spectro- ed to assist patients who suffer from airway narrowing. scopic study of a total solar eclipse in India. It was named later the same year by the British astronomer Table 1. Physical properties of pure gases at RTP Joseph Norman Lockyer and chemist Sir Edward (298 degrees Kelvin and 1 atmosphere pressure) Frankland, the name derived from helios, the Greek for Density Viscosity Thermal sun. It is an inert gas present in the atmosphere (ρ) (η) conductivity (0.00052%) and was used initially in airships and Kg/m3 microPoise W/m K balloons. Today, most commercial helium is recovered from Air 1.184 184.33 0.025 natural gas using a cryogenic separation process, foll- owing which it is refined and liquefied. Liquid helium is Carbon 1.811 148.71 0.017 shipped from the production site to various storage Dioxide facilities worldwide before being distributed in the Helium 0.166 197.61 0.14 gaseous form into cylinders for on-site use.
    [Show full text]
  • Methacholine Challenge Test 1 2
    Methacholine Challenge Test 1 2 What is Methacholine Challenge Test (MCT)? Also, • Do not consume a heavy meal within 2 hours of the test. You can have a light It is a test that measures if your airways narrow after inhaling specific provoking meal e.g. sandwich, soup or salad within 2 hours before the test. agent. The provoking agent used in this test is inhaled methacholine. The degree • Do not wear any tight clothes. of resultant airway narrowing is dependent on each individual’s susceptibility and this airway narrowing will be assessed objectively by measuring the lung function You may also need to stop certain medications before taking the test depending on what clinical questions your physician would like answered based on your MCT changes before and after inhalation of the methacholine in progressively larger results. Different medications have to be stopped at different times before the test doses. Increased airway hyperresponsiveness is usually a hallmark feature of asthma. depending on how long they stay in your body. It is important for you to check with your doctor regarding the safety of stopping Why do I need this operation/procedure? these medications before discontinuing them for the test. Commonly, if you had presented with respiratory symptoms such as shortness of How long before the test? Avoid the following: breath, wheezing, chest tightness or cough, 6weeks Omalizumab your physician may consider doing a MCT to 1week Tiotropium (Spiriva) establish the diagnosis of asthma, especially if 48hours Combination inhalers such as Seretide (fluticasone/ initial lung function tests have not confirmed salmeterol) or Symbicort (budesonide/formoterol) or the diagnosis.
    [Show full text]
  • EMS DIVISION 23.1 Rev. 07/31/2020 PROTOCOL 23 WATER RELATED INCIDENTS
    PROTOCOL 23 WATER RELATED INCIDENTS A. Introduction “Drowning is the process of experiencing respiratory impairment from submersion / immersion in liquid” The word Drowning, should be used to refer to a person who drowned (death) or to a person who was rescued (fatal drowning or non-fatal drowning.) Water Rescue is the process of removing someone from the water in which dangerous conditions are present but the victim shows no signs of respiratory impairment. General Care 1. Initial assessment/Care Protocol 1. 2. Administer 15 L/min Oxygen via NRB mask. 3. Maintain normal body temperature to protect against hypothermia. B. Drowning EMR/BLS 1. Consider concurrent trauma and manage accordingly Protocol 21. 2. Consider insertion of I-gel with NG Tube (Lifeguards only) Procedure 49 and Procedure 12. 3. Determine important history from the patient or bystanders which includes: a) Duration of submersion b) Water temperature c) Any possibility of seizure activity d) Any associated drug or alcohol use e) How the patient entered the water 4. All non-fatal drowning victims must be transported to the closest appropriate facility for evaluation, regardless of how well they may seem to have recovered. Delayed death or complications due to pulmonary edema or aspiration pneumonia are common. ALS 5. Consider insertion of an NG/OG Procedure 12. EMS DIVISION 23.1 Rev. 07/31/2020 PROTOCOL 23 WATER RELATED INCIDENTS 6. Treat dysrhythmias per specific protocols. Consider hypoxia as a primary cause of the dysrhythmias. C. Decompression Sickness/Air Embolism EMR/BLS 1. Evaluate for specific signs and symptoms: a) Pain (primarily joint pain) b) Altered level of consciousness c) Generalized numbness or confusion d) Weakness or paralysis e) External or diagnosed internal bleeding f) Extreme vertigo 2.
    [Show full text]
  • Standardisation of Spirometry
    Eur Respir J 2005; 26: 319–338 DOI: 10.1183/09031936.05.00034805 CopyrightßERS Journals Ltd 2005 SERIES ‘‘ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING’’ Edited by V. Brusasco, R. Crapo and G. Viegi Number 2 in this Series Standardisation of spirometry M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, R. Crapo, P. Enright, C.P.M. van der Grinten, P. Gustafsson, R. Jensen, D.C. Johnson, N. MacIntyre, R. McKay, D. Navajas, O.F. Pedersen, R. Pellegrino, G. Viegi and J. Wanger CONTENTS AFFILIATIONS Background ............................................................... 320 For affiliations, please see Acknowledgements section FEV1 and FVC manoeuvre .................................................... 321 Definitions . 321 CORRESPONDENCE Equipment . 321 V. Brusasco Requirements . 321 Internal Medicine University of Genoa Display . 321 V.le Benedetto XV, 6 Validation . 322 I-16132 Genova Quality control . 322 Italy Quality control for volume-measuring devices . 322 Fax: 39 103537690 E-mail: [email protected] Quality control for flow-measuring devices . 323 Test procedure . 323 Received: Within-manoeuvre evaluation . 324 March 23 2005 Start of test criteria. 324 Accepted after revision: April 05 2005 End of test criteria . 324 Additional criteria . 324 Summary of acceptable blow criteria . 325 Between-manoeuvre evaluation . 325 Manoeuvre repeatability . 325 Maximum number of manoeuvres . 326 Test result selection . 326 Other derived indices . 326 FEVt .................................................................. 326 Standardisation of FEV1 for expired volume, FEV1/FVC and FEV1/VC.................... 326 FEF25–75% .............................................................. 326 PEF.................................................................. 326 Maximal expiratory flow–volume loops . 326 Definitions. 326 Equipment . 327 Test procedure . 327 Within- and between-manoeuvre evaluation . 327 Flow–volume loop examples. 327 Reversibility testing . 327 Method .
    [Show full text]
  • Expiratory Capnography in Asthma
    Eur Respir J, 1994, 7, 318–323 Copyright ERS Journals Ltd 1994 DOI: 10.1183/09031936.94.07020318 European Respiratory Journal Printed in UK - all rights reserved ISSN 0903 - 1936 Expiratory capnography in asthma: B. You*, R. Peslin**, C. Duvivier**, V. Dang Vu*, J.P. Grilliat* Expiratory capnography in asthma: evaluation of various shape indices. B. You, R. *U.M.G., Service de Médecine H, Hôpital Peslin, C. Duvivier, V. Dang Vu, J.P. Grilliat. ERS Journals Ltd 1994. Central, Nancy, France. **INSERM, Unité ABSTRACT: The shape of the capnogram is modified by airway obstruction, and 14, Physiopathologie Respiratoire, Vandœuvre- the evaluation of this deformation, using measurable indices, could allow an indi- les- Nancy, France. rect measurement of bronchial patency. A previous study undertaken in asthmat- Correspondence: B. You ic subjects showed a good correlation between a capnographic index (end-tidal slope) 19 Avenue du Vieux Château and a spirometric parameter (forced expiratory volume in one second as a per- Vandœuvre-les-Nancy centage of predicted (FEV1 %pred)) and suggested the study of other indices. 54500 The correlations between capnographic and spirometric indices were measured France in 10 healthy subjects and 30 asthmatic patients. The usefulness of eight descriptive indices, analysing the successive phases of the capnogram, was assessed by measur- Keywords: Asthma ing their reproducibility and their sensitivity to airway obstruction. The intra- capnography individual and interindividual variabilities (Vi and VI) and the noise/signal ratio carbon dioxide lung function tests (Vi/VI) were measured by comparing the results of two successive capnographic monitoring measurements in 14 asthmatic subjects.
    [Show full text]